Oric Pharmaceuticals Inc

Market Cap

$930M

Healthcare·Biotechnology·🇺🇸 United States·NASDAQ

Healthcare·Biotechnology·🇺🇸·NASDAQ

Stock Price

$7.50-$0.67 (-8.20%)

Jun 5, 2026

52W High $14.4152W Low $7.47

Company Details

ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of therapies to counter the resistance mechanisms in cancers in the United States. Its clinical stage product candidates includ...

CEO

—

IPO Date

Apr 24, 2020

Website

www.oricpharma.com

Key Metrics TTM

Revenue

-100.0% YoY

Net Income

-$135M

EPS (Diluted)

Free Cash Flow

-$111M

Revenue / Share

$0.00

Gross Margin

Operating Margin

Net Margin

FCF Margin

P/S

P/E

Earnings Reports

Q1 2026

May 4, 2026

FY 2025

Feb 23, 2026

Q4 2025

Feb 23, 2026

$0-100.0%

Q3 2025

Nov 13, 2025

Q2 2025

Aug 12, 2025

Revenue & Profitability

Valuation

Operating Cash Flow

CapEx Spend

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

War Chest

Shares Outstanding

Revenue Per Employee

Revenue / Employee